The https://www.digitalpharmalab.com/ website you are currently visiting is the property of D2A SAS.

Terms and conditions of use

Effective 01/01/2025

The purpose of these general conditions of use (hereinafter referred to as the "GCU") is to provide a legal framework for the provision of the site and its services by and to define the conditions of access to and use of the services by the "User".

These GCU are available on the site under the heading "GCU".

Article 1: Legal information

The https://www.digitalpharmalab.com/ website is published by D2A SAS, a company with share capital of 18,705 euros, registered with the Paris Trade and Companies Register under number 831 267 315, headquartered at 69 boulevard Pereire 75017 Paris.

Phone number 06 71 55 33 24

E-mail address: admin@d2a.zone

The Publishing Director is: Didier Tranchier

The host of the https://www.digitalpharmalab.com/ website is Gandi, whose head office is located at 63/65 Boulevard Masséna 75013 Paris - France.

ARTICLE 2: Site access

The https://www.digitalpharmalab.com/ website provides the User with free access to the following services:

Presentation of Digital Pharma Lab programs

The site is accessible free of charge from any location to any User with Internet access. All costs incurred by the User to access the service (hardware, software, Internet connection, etc.) are at the User's expense.

ARTICLE 3: Data collection and confidentiality

Users are informed that the personal information collected may be subject to computerized processing, that it may be compiled in the form of a file and that, in accordance with the provisions of article 39 of the amended "Informatique et Libertés" law, you have the right to access, rectify and object to any data concerning you by contacting us by e-mail at admin@d2a.zone.

The information communicated via the forms on the site is necessary to respond to and process users' requests.

D2A SAS does not pass on the personal information collected to third parties for the purpose of commercial prospecting.

ARTICLE 4: Intellectual property

Trademarks, logos, signs and all site content (text, images, sound, etc.) are protected by the French Intellectual Property Code, and more specifically by copyright.

The trademarks Digital Pharma Lab, Étincelle Digitale, Coalition Next, Coalition Innosanté, Open Design Thinking are registered trademarks of D2A SAS. Any representation and/or reproduction and/or partial or total use of these trademarks, of any nature whatsoever, is totally prohibited.

The User must request prior authorization from the site for any reproduction, publication or copy of the various contents. The User undertakes to use the contents of the site in a strictly private context. Any use for commercial or advertising purposes is strictly forbidden.

Any total or partial representation of this site, by any means whatsoever, without the express authorization of the website operator, would constitute an infringement punishable by Article L 335-2 et seq. of the French Intellectual Property Code.

In accordance with article L122-5 of the French Intellectual Property Code, Users who reproduce, copy or publish protected content must cite the author and source.

ARTICLE 5: Liability

The sources of the information published on https://www.digitalpharmalab.com/ are deemed reliable, but the site does not guarantee that it is free from defects, errors or omissions.

The information provided is for general guidance only, and is not contractually binding. Despite regular updates, the https://www.digitalpharmalab.com/ website cannot be held responsible for any changes in administrative or legal provisions occurring after publication. Similarly, the site cannot be held responsible for the use and interpretation of the information contained on this site.

The https://www.digitalpharmalab.com/ site cannot be held responsible for any viruses that may infect the computer or any other hardware of the Internet user, following use, access or downloading from this site.

The site cannot be held liable in the event of force majeure or the unforeseeable and insurmountable act of a third party.

ARTICLE 6: Hypertext links

Hypertext links may be present on the site. Users are informed that by clicking on these links, they will leave the https://www.digitalpharmalab.com/ site . The latter has no control over the web pages to which these links lead and cannot, under any circumstances, be held responsible for their content.

ARTICLE 7: Cookies

The User is informed that when visiting the site, a cookie may be automatically installed on his/her browser.

Cookies are small files stored temporarily on the hard disk of the User's computer by your browser and which are necessary for the use of the https://www.digitalpharmalab.com/ website . Cookies do not contain any personal information and cannot be used to identify anyone. A cookie contains a unique identifier, randomly generated and therefore anonymous. Some cookies expire at the end of the User's visit, others remain.

The information contained in cookies is used to improve the https://www.digitalpharmalab.com/ website .

By browsing the site, the User accepts them.

The User may deactivate these cookies using the settings in his browser software.

ARTICLE 8: Applicable law and jurisdiction

This contract is governed by French law. In the event of failure to resolve a dispute between the parties amicably, the French courts shall have sole jurisdiction.

If you have any questions concerning the application of these GTUs, you may contact the publisher at the address given in article 1.